 | PRD_000901 | Name: | thiomuracin A derivative | Formula: | C53 H54 N13 O9 S6 | Definition date: | 2012-12-26 | Last modified: | 2023-11-03 |
|
 | PRD_000197 | Name: | ALPHA LICHENICIDIN PREPEPTIDE | Formula: | C142 H226 N36 O41 S5 | Description: | LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL
MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND
SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS
WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS.
THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE
MODIFIED PRECURSOR. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000956 | Name: | N-[(2S)-1-({(2S)-1-{[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]amino}-4-[(R)-methylsulfinyl]-1-oxobutan-2-yl}amino)-3-methyl-1-oxobutan-2-yl]hexanamide | Formula: | C25 H49 N3 O6 S | Description: | Carmaphycin A, bound form | Definition date: | 2014-01-29 | Last modified: | 2023-11-03 |
|
 | PRD_000198 | Name: | BETA LICHENICIDIN PREPEPTIDE | Formula: | C133 H200 N36 O37 S4 | Description: | LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL
MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND
SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS
WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS.
THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE
MODIFIED PRECURSOR. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_001184 | Name: | Dimethyl FK228 | Formula: | C26 H42 N4 O6 S2 | Description: | DIMETHYL FK228 IS THE REDUCED AND MODIFIED FORM OF ROMIDEPSIN. THE DISULFIDE INTRAMOLECULAR LINKAGE OF ROMIDEPSIN IS BROKEN, AND BOTH SULFHYDRYL GROUPS ARE METHYLATED. | Definition date: | 2014-03-05 | Last modified: | 2023-11-03 |
|
 | PRD_000428 | Name: | CYCLOTHEONAMIDE A | Formula: | C36 H46 N9 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000456 | Formula: | C39 H67 N12 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_001255 | Name: | Promothiocin A | Formula: | C36 H47 N11 O8 S2 | Definition date: | 2014-12-10 | Last modified: | 2023-11-03 |
|
 | PRD_000554 | Name: | Cyclotheonamide A | Formula: | C36 H46 N9 O8 | Definition date: | 2012-02-03 | Last modified: | 2023-11-03 |
|
 | PRD_000555 | Name: | AERUGINOSIN 298-A | Formula: | C30 H48 N6 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_002098 | Formula: | C29 H43 N10 O9 | Definition date: | 2013-08-07 | Last modified: | 2023-11-03 |
|
 | PRD_002239 | Name: | N-[5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl]-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | Formula: | C32 H57 N7 O7 S | Definition date: | 2017-08-02 | Last modified: | 2023-11-03 |
|
 | PRD_002282 | Name: | (3S,6S,9S,15aR)-6,9-dibenzyl-3-{6,6-dihydroxy-6-[(2S)-oxiran-2-yl]hexyl}octahydro-2H-pyrido[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10(3H,12H)-tetrone | Formula: | C34 H44 N4 O7 | Definition date: | 2017-09-13 | Last modified: | 2023-11-03 |
|
 | PRD_002289 | Name: | 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]propanamide | Formula: | C68 H85 N13 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
 | PRD_002290 | Name: | 4-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]butan-1-aminium | Formula: | C69 H90 N13 O12 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
 | PRD_000727 | Name: | PYOVERDIN G173 Fe Complex | Formula: | C49 H66 Fe N13 O21 | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000842 | Name: | PTA-SFTI INHIBITOR | Formula: | C66 H106 N20 O18 S2 | Description: | Bowman-Birk Inhibitor | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000846 | Name: | TRYPSIN INHIBITOR 1 | Formula: | C66 H106 N20 O18 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000117 | Name: | ARYLOMYCIN A2 | Formula: | C42 H60 N6 O11 | Description: | ARYLOMYCIN A2 IS A BIARYL-BRIDGED LIPOPEPTIDE. THE SCAFFOLD IS MADE OF TWO PARTS: (1) N-TERM EXOCYCLIC TRIPEPTIDE (2)
A TRICYCLIC PEPTIDE, WITH [3,3] BIARYL BOND BETWEEN RESIDUE 4 AND 6 AN ISO-C12 FATTY ACID IS LINKED TO RESIDUE 1. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000142 | Name: | Cyclosporin A | Formula: | C62 H111 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000143 | Name: | Cyclosporin D | Formula: | C64 H115 N11 O12 S | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000144 | Name: | Cyclosporin C | Formula: | C62 H111 N11 O13 | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS
FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000150 | Name: | GRAMICIDIN A | Formula: | C99 H140 N20 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000151 | Name: | GRAMICIDIN B | Formula: | C97 H139 N19 O17 | Description: | GRAMICIDIN B IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
 | PRD_000152 | Name: | GRAMICIDIN D | Formula: | C99 H140 N20 O17 | Description: | GRAMICIDIN D IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 1).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|